1. Home
  2. ADV vs NUVB Comparison

ADV vs NUVB Comparison

Compare ADV & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADV
  • NUVB
  • Stock Information
  • Founded
  • ADV 1987
  • NUVB 2018
  • Country
  • ADV United States
  • NUVB United States
  • Employees
  • ADV N/A
  • NUVB N/A
  • Industry
  • ADV Business Services
  • NUVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADV Consumer Discretionary
  • NUVB Health Care
  • Exchange
  • ADV Nasdaq
  • NUVB Nasdaq
  • Market Cap
  • ADV 977.6M
  • NUVB 850.3M
  • IPO Year
  • ADV N/A
  • NUVB N/A
  • Fundamental
  • Price
  • ADV $3.44
  • NUVB $2.70
  • Analyst Decision
  • ADV Strong Buy
  • NUVB Strong Buy
  • Analyst Count
  • ADV 1
  • NUVB 6
  • Target Price
  • ADV N/A
  • NUVB $6.33
  • AVG Volume (30 Days)
  • ADV 537.8K
  • NUVB 2.3M
  • Earning Date
  • ADV 11-07-2024
  • NUVB 11-06-2024
  • Dividend Yield
  • ADV N/A
  • NUVB N/A
  • EPS Growth
  • ADV N/A
  • NUVB N/A
  • EPS
  • ADV N/A
  • NUVB N/A
  • Revenue
  • ADV $3,990,708,000.00
  • NUVB $2,162,000.00
  • Revenue This Year
  • ADV N/A
  • NUVB N/A
  • Revenue Next Year
  • ADV $2.10
  • NUVB N/A
  • P/E Ratio
  • ADV N/A
  • NUVB N/A
  • Revenue Growth
  • ADV N/A
  • NUVB N/A
  • 52 Week Low
  • ADV $2.60
  • NUVB $1.22
  • 52 Week High
  • ADV $4.95
  • NUVB $4.16
  • Technical
  • Relative Strength Index (RSI)
  • ADV 55.79
  • NUVB 54.67
  • Support Level
  • ADV $3.05
  • NUVB $2.44
  • Resistance Level
  • ADV $3.59
  • NUVB $3.07
  • Average True Range (ATR)
  • ADV 0.28
  • NUVB 0.18
  • MACD
  • ADV 0.02
  • NUVB -0.00
  • Stochastic Oscillator
  • ADV 46.43
  • NUVB 57.78

About ADV Advantage Solutions Inc.

Advantage Solutions Inc is the provider of outsourced sales and marketing solutions to consumer goods companies and retailers. It has a technology-enabled platform of sales and marketing services like headquarter sales, retail merchandising, in-store sampling, digital commerce, and shopper marketing. For brands and retailers of all sizes, the firm helps to get the right products on the shelf and into the hands of consumers. The company helps its clients to sell more while spending less. Advantage has offices throughout North America and strategic investments in select markets throughout Africa, Asia, Australia, and Europe through which it services the global needs of multinational, regional, and local manufacturers. Its services are provided across two segments sales and marketing.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).

Share on Social Networks: